4 More Private Healthcare Institutions Apply to Import COVID-19 Vaccines Due to High Demand for Sinovac Vaccines

So lest you’ve been living under a rock, you would surely be familiar with the local government’s stock of Sinovac COVID-19 vaccines…

And the overwhelming demand for them.

Just to put it into perspective, a woman was willing to pay a whopping S$1000 for a spot in the queue.

S$1,000. What in the world.

You can read more on that here.

So yeah, the demand and supply curve for Sinovac vaccines is kind of imbalanced right now…

Though thankfully, it appears that ‘help’ is on the way.

4 More Private Healthcare Institutions Apply to Import COVID-19 Vaccines Due to High Demand for Sinovac Vaccines

Lest you’re unaware, 24 private healthcare institutions were previously designated to apply the 200,000 strong stock of Sinovac vaccines.

And now, four more private healthcare institutions are set to join the fray.

According to Channel News Asia, the four institutions have applied for the importation of COVID-19 vaccines under the Special Access Route (SAR).

Their identities were not revealed.

The revelation would certainly benefit those keen to get a non-mRNA vaccine, seeing how vaccination sites and supply have been pressurised of late.

In fact, one clinic has stated that they have 4,000 people lined up for vaccination appointments. Bookings are reportedly stacked up till end-September.

Alternatives

For those unfamiliar with the SAR, it should not be confused with the SAR-21, a flirtatious entity that has slept with trillions of SAF soldiers.

Rather, it’s the Special Access Route, a pathway that allows the healthcare sector to bring in unregistered COVID-19 vaccines.

Though unregistered, these vaccines would at least have to be approved by the World Health Organisation (WHO).

These vaccines would appeal to those who’re either unable or unwilling to take the two authorised COVID-19 vaccines in Singapore: Pfizer-BioNTech and Moderna vaccines.

Based on mRNA technology, these two vaccines have been theorised by some to “alter DNA” or even “turn people into hybrids”.

Naturally, these claims are true. I mean false.

This article here appears to debunk those myths.

It should be noted, however, that the Sinovac vaccine does not come without its own risks.

Apart from a success rate that’s significantly lower than the Pfizer-BioNTech and Moderna vaccines, it has also caused hives in a couple of patients.

No serious consequence, however, has been determined for now.

Featured Image: PhotobyTawat / Shutterstock.com